Treatment of disequilibrium and nausea in the SRI discontinuation syndrome.
Schechter
J O
JO
D001259:Ataxia / Q000139:chemically induced / Q000188:drug therapy; D004244:Dizziness / Q000139:chemically induced* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D009325:Nausea / Q000139:chemically induced* / Q000188:drug therapy*; D017374:Paroxetine / Q000009:adverse effects*; D008517:Phytotherapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy* / Q000209:etiology; D019862:Zingiberales / Q000627:therapeutic use*
D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors